Potency testing of anti-cancer immune cells – easy, quantitative, in real time

16th September 2021
10:00 am - 10:45 am CEST
Immuno-Oncology therapies mobilize the human immune system to fight against tumor cells. Since the first immuno-oncology treatment was approved in 2010, this type of therapy has proven it´s great potential in cancer therapies worldwide. Visit our webinar to explore how to easily unravel the effectiveness of stimulated lymphocytes, monoclonal antibodies or checkpoint inhibitors by using xCELLigence Real Time Cell Analyzer. Without any cell labelling, xCELLigence RTCA systems allow the detection of target cell proliferation and killing in a highly sensitive, quantitative manner. Automated real-time measurements at low or high-throughput level result in highly consistent, user-independent results.

    * You can change your preference or unsubscribe at any time with the links included in any of our emails, or by contacting us at info@ols-bio.de. We will treat your information with respect and in accordance with the legal data protection regulations and our privacy policy.

    Subscribe for our newsletter

    e-mail required
    By submitting my data and sending the registration, I agree to receive the newsletter ordered here by email. My data will not be disclosed to third parties. I can revoke this consent at any time. More detailed information in the Privacy Policy section
    OLS OMNI Life Science Your Partner in Cell Research
    Imprint | Privacy Policy | Terms and Conditions